Drug recall · June 11, 2014
Marcaine recall
Why: Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.
- Lots / codes
Lot #: 34-440-DD, Exp 10/15
- Quantity
- 85,680 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide.
- Initiated
- April 21, 2014 · Voluntary: Firm initiated
- Classified
- June 5, 2014
- Reported
- June 11, 2014
- Ended
- March 16, 2017
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.